Nebula Genomics Signs Agreement for Pilot Project with EMD Serono

448

SAN FRANCISCO, & BOSTON–(BUSINESS WIRE)–Nebula Genomics, which operates a technology platform containing genome-sequencing data, has signed an agreement with EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, for EMD Serono to access genomic data on Nebula’s blockchain-based network for genomic data sharing. Nebula aims to help EMD Serono enhance its research efforts by supporting its scientists as they develop potential new medicines, using…

 

http://www.businesswire.com/news/home/20190611005091/en/Nebula-Genomics-Signs-Agreement-Pilot-Project-EMD/